GSK (GSK) Earnings Date, Estimates & Call Transcripts $43.67 +0.54 (+1.25%) (As of 09/6/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueGSK Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GSK Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. GSK Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241$0.90$0.90$0.90 Q2 20241$1.00$1.00$1.00 Q3 20241$1.24$1.24$1.24 Q4 20241$0.84$0.84$0.84 FY 20244$3.98$3.98$3.98 Q1 20251$1.11$1.11$1.11 Q2 20251$1.03$1.03$1.03 Q3 20251$1.34$1.34$1.34 Q4 20251$0.98$0.98$0.98 FY 20254$4.46$4.46$4.46 Q1 20261$1.12$1.12$1.12 Get GSK Earnings AlertsEnter your email address below to receive the latest news and earnings results for GSK and its competitors with MarketBeat's FREE daily newsletter. GSK Earnings Date and InformationGSK has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based off prior year's report dates.Read More GSK Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/6/2024(Estimated)------- 5/1/2024Q1 2024$0.94$1.09+$0.15$1.53$8.98 billion$9.34 billion 1/31/2024Q4 2023$0.76$0.72($0.04)$1.23$9.79 billion$10.00 billion 11/1/2023Q3 2023$1.09$1.26+$0.17$1.62$9.72 billion$10.32 billion 7/26/2023Q2 2023$0.85$0.97+$0.12$0.94$8.49 billion$8.98 billion 4/26/2023Q1 2023$0.85$0.90+$0.05$0.90$8.55 billion$8.45 billion 2/1/2023Q4 2022$0.59$0.64+$0.05$0.36$8.30 billion$8.66 billion Get the Latest News and Ratings for GSK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. 11/2/2022Q3 2022$0.90$1.09+$0.19($3.76)$7.75 billion$9.22 billion 7/27/2022Q2 2022$0.76$0.87+$0.11$1.22$9.35 billion$8.71 billion 4/27/2022Q1 2022$0.77$0.88+$0.11$0.80$11.97 billion$13.12 billion 2/9/2022Q4 2021$0.63$0.69+$0.06$0.98$12.62 billion$12.84 billion 10/27/2021Q3 2021$0.80$1.01+$0.21$1.38$11.92 billion$12.51 billion 7/28/2021Q2 2021$0.54$0.79+$0.25$0.81$10.55 billion$11.31 billion 4/28/2021Q1 2021$0.63$0.63-$0.67$10.66 billion$10.23 billion 2/2/2021Q4 2020$0.64$0.62($0.02)$0.88$8.71 billion$8.74 billion 10/28/2020Q3 2020$0.78$0.92+$0.14$1.19$11.27 billion$11.17 billion 7/29/2020Q2 2020$0.49$0.48($0.01)($0.17)$9.60 billion$9.46 billion 4/29/2020Q1 2020$0.79$0.97+$0.18$1.14$10.95 billion$11.64 billion 2/5/2020Q4 2019$0.68$0.64($0.04)$0.61$11.77 billion$11.46 billion 10/30/2019Q3 2019$0.85$0.95+$0.10$1.13$11.34 billion$11.57 billion GSK Earnings - Frequently Asked Questions When is GSK's earnings date? GSK has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based off last year's report dates. Learn more on GSK's earnings history. What guidance has GSK issued on next quarter's earnings? GSK updated its FY 2024 earnings guidance on Wednesday, July, 31st. The company provided earnings per share (EPS) guidance of 1.710-1.740 for the period, compared to the consensus estimate of 4.040. The company issued revenue guidance of $40.9 billion-$41.7 billion, compared to the consensus revenue estimate of $40.7 billion. How much revenue does GSK generate each year? GSK (NYSE:GSK) has a recorded annual revenue of $31.45 billion. How much profit does GSK generate each year? GSK (NYSE:GSK) has a recorded net income of $6.13 billion. GSK has generated $2.76 earnings per share over the last four quarters. What is GSK's price-to-earnings ratio? GSK (NYSE:GSK) has a trailing price-to-earnings ratio of 15.82 and a forward price-to-earnings ratio of 10.52. The price/earnings-to-growth ratio is 1.42. What is GSK's EPS forecast for next year? GSK's earnings are expected to grow from $4.15 per share to $4.51 per share in the next year, which is a 8.67% increase. More Earnings Resources from MarketBeat Related Companies: AstraZeneca Earnings Results Novartis Earnings Results Sanofi Earnings Results Takeda Pharmaceutical Earnings Results Moderna Earnings Results Teva Pharmaceutical Industries Earnings Results BioNTech Earnings Results BeiGene Earnings Results Genmab A/S Earnings Results Viatris Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Is Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 EarningsNVIDIA: Analysts Bullish Ahead of Earnings - Is It a Buy Now? This page (NYSE:GSK) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GSK plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GSK With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GSK Stock Alerts